COVID-19 Innovation Fund Winners Announced

Given the unprecedented suspension of all non-essential research due to the COVID-19 pandemic, the Innovation Fund Provincial Oversight Committee (IFPOC) gave SEAMO the opportunity to both repurpose 2019 Innovation Fund monies and fast track the 2020 competition in support of COVID-19 research.      

SEAMO issued a call for proposals on April 6, 2020 and, by the April 15, 2020 deadline, we had received thirty-seven (37) applications spanning 12 departments and 20 specialties. The total value of the applications was approximately $4.2 million.  Steven Smith, Vice-Dean Research, Queen’s Faculty of Heath Sciences, was impressed with the depth, breadth and quality of the applications, given the very short timeline for submissions.   Unfortunately, with a limited budget of $670K, SEAMO is only able to fund six (6) projects.

Below you’ll find a list of the researchers and their COVID-19 initiatives. Each project strives to better understand the virus while developing innovative solutions to combat COVID-19. Stay tuned for more about each of these innovative projects. 

Dr. Archer

 

 Stephen Archer - Synthesis and preclinical testing of novel small molecule therapies for COVID-19 

 

Dr. James

 

 Paula James - COVID-19 Coagulopathy: Understanding and Treating a Novel Entity
 

 

Dr. Maslove Dr. Rauh

David Maslove and Michael Rauh- COVID-19 and the Genetics of Mortality in Critical Care (GenOMICC)

 

Dr. Siemens

 

Robert Siemens - Role of BCG-induced innate immune memory in the protection against coronavirus

 

Dr. ten Hove

 

Martin ten Hove - Coronavirus infection of the ocular mucosa to model infection and systemic immunity

 

Dr. Vanner

 

Stephen Vanner - The application of metabolomics to enhance detection of COVID-19 and predict disease severity: A proof-of-principle study